Centessa Pharmaceuticals plc
CNTA
$29.07
$0.561.96%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.89M | -50.34M | -26.14M | -111.33M | -42.57M |
| Total Depreciation and Amortization | 237.00K | 226.00K | 217.00K | 90.00K | 236.00K |
| Total Amortization of Deferred Charges | 271.00K | 293.00K | 312.00K | 140.00K | -- |
| Total Other Non-Cash Items | 7.34M | 8.92M | 6.80M | 43.12M | 8.91M |
| Change in Net Operating Assets | -11.26M | 18.45M | -38.44M | 25.18M | 12.03M |
| Cash from Operations | -58.31M | -22.45M | -57.25M | -42.80M | -21.39M |
| Capital Expenditure | -234.00K | -126.00K | -- | 0.00 | -34.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.18M | -39.83M | -222.39M | 25.00M | 45.00M |
| Cash from Investing | 61.95M | -39.95M | -222.39M | 25.00M | 44.96M |
| Total Debt Issued | -- | -- | -- | 109.34M | -- |
| Total Debt Repaid | -- | -- | -- | -110.10M | -- |
| Issuance of Common Stock | 3.56M | 1.71M | 7.87M | 5.31M | 246.95M |
| Repurchase of Common Stock | -125.00K | -4.49M | -- | -- | -970.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 4.39M | -4.79M | -1.59M | -- |
| Cash from Financing | 3.44M | 1.61M | 3.09M | 2.96M | 245.98M |
| Foreign Exchange rate Adjustments | -501.00K | -113.00K | -1.52M | 3.03M | -1.90M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.57M | -60.91M | -278.07M | -11.81M | 267.65M |